MKI67 and breast cancer: BC patient lymphocytes were ADRB3high Ki-67-, which arrested in early G1 phase, whereas ADRB3high Ki-67+ MDSCs with highly replicative potential lead to excessive inflammation and form a shied that protects DTC from immune effector cells.